Immunity Pharma

Compounds for Treating Neurodegenerative Diseases

Active Pre-Funding Startup Jerusalem Founded 2007-03

Website ↗

Immunity Pharma (IPL) develops therapies for neurodegenerative diseases with an initial focus on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. IPL's drugs are peptides with biologic activity. The peptides stimulate therapeutic cell-signaling processes that are often down-regulated in neurodegenerative diseases. The drugs mitigate…